{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:46Z","timestamp":1783660426580,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f447) and validation (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA)\n                      <jats:italic>T<\/jats:italic>\n                      -score \u2264\u22122.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of osteoporosis was 11.7% (75\/639). Six independent risk factors were identified: advanced age (OR\u202f=\u202f4.054, 95%CI 2.281\u20137.237), disease duration (OR\u202f=\u202f1.068, 95%CI 1.026\u20131.11), psoriatic arthritis (OR\u202f=\u202f2.178, 95%CI 1.243\u20133.796), vitamin D deficiency (OR\u202f=\u202f5.148, 95%CI 1.986\u201317.672), systemic corticosteroid use (OR\u202f=\u202f3.501, 95%CI 1.756\u20136.826), male sex (OR\u202f=\u202f0.399, 95%CI 0.229\u20130.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities. DCA confirmed the clinical utility of the model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1826823","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:24:07Z","timestamp":1783657447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhilong","family":"Wang","sequence":"first","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Third Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoning","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsheng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Hospital, National Centre of Gerontology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12016-025-09089-4","article-title":"Systemic psoriasis: from molecular mechanisms to global management strategies","volume":"68","author":"Prema","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"A reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/13697137.2021.1945027","article-title":"Fracture risk assessment by the FRAX model","volume":"25","author":"McCloskey","year":"2022","journal-title":"Climacteric"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.18632\/oncotarget.22260","article-title":"Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis","volume":"9","author":"Bai","year":"2018","journal-title":"Oncotarget"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"925503","DOI":"10.3389\/fimmu.2022.925503","article-title":"Impact of chronic inflammation in psoriasis on bone metabolism","volume":"13","author":"Saalbach","year":"2022","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"604055","DOI":"10.3389\/fimmu.2020.604055","article-title":"IL-33\/vitamin D crosstalk in psoriasis-associated osteoporosis","volume":"11","author":"De Martinis","year":"2020","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10654-023-01075-4","article-title":"Vitamin D and human health: evidence from mendelian randomization studies","volume":"39","author":"Fang","year":"2024","journal-title":"Eur J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113712","article-title":"Bone mineral density, osteoporosis, and fracture risk in adult patients with psoriasis or psoriatic arthritis: a systematic review and Meta-analysis of observational studies","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-022-06435-6","article-title":"Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan","volume":"33","author":"Vandenput","year":"2022","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.semarthrit.2016.05.005","article-title":"Prevalence and risk factors of low bone mineral density in psoriatic arthritis: a systematic review","volume":"46","author":"Chandran","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2515690x231211663","DOI":"10.1177\/2515690X231211663","article-title":"Comparing vitamin D level between patients with psoriasis and healthy individuals: a systematic review and Meta-analysis","volume":"28","author":"Moosazadeh","year":"2023","journal-title":"J Evid Based Integr Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ad.2019.02.005","article-title":"Osteoporosis and psoriasis","volume":"110","author":"Mu\u00f1oz-Torres","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ageing\/afu104","article-title":"Understanding vitamin D deficiency","volume":"43","author":"Sahota","year":"2014","journal-title":"Age Ageing"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of Potent and Very Potent Topical Corticosteroids and the risk of osteoporosis and major osteoporotic fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/jbmr.2521","article-title":"Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients","volume":"30","author":"Kocijan","year":"2015","journal-title":"J Bone Mineral Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-007-0725-8","article-title":"Bone mineral density and bone turnover in patients with psoriatic arthritis","volume":"27","author":"Borman","year":"2008","journal-title":"Clin Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/1346-8138.12546","article-title":"Psoriasis and bone mineral density: implications for long-term patients","volume":"41","author":"D\u2019Epiro","year":"2014","journal-title":"J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/jid.2008.432","article-title":"Psoriasis and osteoporosis: a sex-specific association?","volume":"129","author":"Dreiher","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-025-07312-3","article-title":"Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis","volume":"44","author":"Yeti\u015fir","year":"2025","journal-title":"Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5152\/ArchRheumatol.2025.25030","article-title":"Effect of nutritional ingredients on disease activation in psoriatic arthritis","volume":"40","author":"Varkal","year":"2025","journal-title":"Arch Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/eurjrheum.2025.24052","article-title":"The relationship between the monocyte-to-high-density lipoprotein-cholesterol ratio and disease activity in patients with psoriatic arthritis","volume":"12","author":"Varkal","year":"2025","journal-title":"Eur J Rheumatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1826823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:24:08Z","timestamp":1783657448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1826823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":29,"alternative-id":["10.3389\/fmed.2026.1826823"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1826823","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1826823"}}